Carlyle 13F annual report
Carlyle is an investment fund managing more than $1.05 trillion ran by Jeffrey Ferguson. There are currently 31 companies in Mr. Ferguson’s portfolio. The largest investments include QuidelOrtho and ZoomInfo Technologies, together worth $603 billion.
$1.05 trillion Assets Under Management (AUM)
As of 2nd August 2024, Carlyle’s top holding is 11,520,751 shares of QuidelOrtho currently worth over $383 billion and making up 36.3% of the portfolio value.
Relative to the number of outstanding shares of QuidelOrtho, Carlyle owns less than 0.2% of the company.
In addition, the fund holds 17,244,747 shares of ZoomInfo Technologies worth $220 billion, whose value fell 41.8% in the past six months.
The third-largest holding is Soleno Therapeutics Inc worth $166 billion and the next is Gds Hldgs Ltd worth $37.8 billion, with 4,072,624 shares owned.
Currently, Carlyle's portfolio is worth at least $1.05 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Carlyle
The Carlyle office and employees reside in Washington, District Of Columbia. According to the last 13-F report filed with the SEC, Jeffrey Ferguson serves as the General Counsel at Carlyle.
Recent trades
In the most recent 13F filing, Carlyle revealed that it had opened a new position in
Aon plc and bought 4,973 shares worth $1.46 billion.
On the other hand, there are companies that Carlyle is getting rid of from its portfolio.
Carlyle closed its position in Vitru Ltd on 9th August 2024.
It sold the previously owned 6,246,471 shares for $94 billion.
Jeffrey Ferguson also disclosed a decreased stake in QuidelOrtho by approximately 0.1%.
This leaves the value of the investment at $383 billion and 11,520,751 shares.
One of the average hedge funds
The two most similar investment funds to Carlyle are Bloombergsen and U S Global Investors Inc. They manage $1.05 trillion and $1.05 trillion respectively.
Jeffrey Ferguson investment strategy
Carlyle’s portfolio is diversified across 8 sectors.
Currently, their heaviest sector is Health Care — making up 59.1% of
the total portfolio value.
The fund focuses on investments in the United States as
48.4% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
23% of the total holdings value.
On the other hand, large-cap stocks make up 12.9% of the portfolio.
The average market cap of the portfolio companies is close to $7.86 billion.
The complete list of Carlyle trades based on 13F SEC filings
These positions were updated on August 9th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| QuidelOrtho Corporation |
7.54%
11,520,751
|
$382,719,348,000 | 36.35% |
| ZoomInfo Technologies Inc. |
34.29%
17,244,747
|
$220,215,419,000 | 20.91% |
| Soleno Therapeutics Inc |
No change
4,071,562
|
$166,364,023,000 | 15.80% |
| Vitru Ltd |
Closed
6,246,471
|
$94,009,389,000 | |
| Gds Hldgs Ltd |
No change
4,072,624
|
$37,834,677,000 | 3.59% |
| Phathom Pharmaceuticals Inc |
No change
3,496,808
|
$35,842,282,000 | 3.40% |
| Verona Pharma Plc |
No change
2,457,500
|
$35,510,875,000 | 3.37% |
| Getty Images Holdings Inc |
No change
9,212,799
|
$30,033,726,000 | 2.85% |
| Hillevax Inc |
No change
1,838,486
|
$26,437,429,000 | 2.51% |
| Jasper Therapeutics Inc |
No change
1,066,189
|
$24,202,490,000 | 2.30% |
| Q32 Bio Inc |
No change
1,102,741
|
$19,198,721,000 | 1.82% |
| SEACOR Marine Holdings Inc |
No change
1,314,164
|
$17,728,072,000 | 1.68% |
| Invitation Homes Inc |
No change
477,500
|
$17,137,475,000 | 1.63% |
| CubeSmart |
No change
220,500
|
$9,959,985,000 | 0.95% |
| Complete Solaria Inc |
No change
4,936,483
|
$5,479,496,000 | 0.52% |
| Reneo Pharmaceuticals Inc |
No change
2,698,957
|
$4,156,394,000 | 0.39% |
| Smart Sh Global Ltd |
No change
4,810,209
|
$4,130,045,000 | 0.39% |
| Krispy Kreme, Inc. |
No change
340,748
|
$3,666,448,000 | 0.35% |
| Adicet Bio Inc |
No change
2,948,718
|
$3,597,436,000 | 0.34% |
| Spruce Biosciences, Inc. |
No change
2,896,518
|
$1,520,093,000 | 0.14% |
| Aon plc. |
Opened
4,973
|
$1,459,973,000 | 0.14% |
| N-able Inc |
No change
93,732
|
$1,427,538,000 | 0.14% |
| Broadcom Inc. |
No change
755
|
$1,212,032,000 | 0.12% |
| SolarWinds Corp |
No change
93,735
|
$1,129,507,000 | 0.11% |
| NuCana plc |
Closed
3,333,333
|
$845,333,000 | |
| Nu Hldgs Ltd |
23.39%
55,417
|
$714,325,000 | 0.07% |
| DoorDash Inc |
No change
4,156
|
$452,090,000 | 0.04% |
| NuCana plc |
Opened
133,333
|
$339,999,000 | 0.03% |
| Confluent Inc |
Closed
7,683
|
$234,485,000 | |
| Spyre Therapeutics Inc |
No change
9,620
|
$226,936,000 | 0.02% |
| Meta Data Limited |
No change
314,400
|
$133,306,000 | 0.01% |
| Exicure Inc |
No change
281,636
|
$88,772,000 | 0.01% |
| Effector Therapeutics Inc |
No change
192,884
|
$55,936,000 | 0.01% |
| Molecular Templates Inc |
No change
13,333
|
$14,800,000 | 0.00% |
| No transactions found | |||
| Showing first 500 out of 34 holdings | |||
Hedge funds similar to Carlyle
- Pdt Partners
- Syon Capital
- Spc
- Crestline Management, L.P.
- Charles Schwab Trust Co
- Rhenman & Partners Asset Management Ab
- Ge Investment Management Corp
- Bloombergsen
- U S Global Investors Inc
- Narwhal Capital Management
- Oak Ridge Investments
- Parcion Private Wealth
- Trust Co Of Virginia va
- Lyell Wealth Management, L.P.